Hikma partners with Perrigo

Hikma will market a range of Perrigo consumer healthcare products in the Middle East and North Africa (MENA) region after signing a licensing and distribution agreement with Perrigo’s Omega Pharma OTC affiliate. Under the terms of the deal, Hikma will have the “exclusive right to licence and distribute more than 30 consumer healthcare products – including Davitamon, Prevalin, XLS Medical, Dermalex and Paranix–in all its MENA markets, with the exception of current arrangements in place”.